Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- SPARTANIndependent statistical analysis of Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SPARXIndependent statistical analysis of Study in Parkinson's Disease of Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01506479).
- Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion “Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma”: Complete Statistical AnalysisIndependent statistical analysis of Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma": primary endpoint results, effect estimate with confidence…
- Special Drug Use Surveillance of Vonoprazan for “Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use”: Complete Statistical AnalysisIndependent statistical analysis of Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use": primary endpoint results, effect estimate with confidence…
- Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation): Complete Statistical AnalysisIndependent statistical analysis of Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01329380).
- Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI]): Complete Statistical AnalysisIndependent statistical analysis of Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI]): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan): Complete Statistical AnalysisIndependent statistical analysis of Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Special Survey on Parkinson’s Disease (PD) Patients Without Concomitant Use of L-Dopa: Complete Statistical AnalysisIndependent statistical analysis of Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Specified Drug-Use Survey of Trelagliptin Tablets “Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease”: Complete Statistical AnalysisIndependent statistical analysis of Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease": primary endpoint results, effect…
- SPECSIndependent statistical analysis of SPECS: Safe Pediatric Euglycemia in Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00443599).
- Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC: Complete Statistical AnalysisIndependent statistical analysis of Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Spectroscopy Versus Standard Care in Cervical Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Spectroscopy Versus Standard Care in Cervical Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00529464).
- SPECTRUMIndependent statistical analysis of Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Speech Locator In-car Performance Evaluation: Complete Statistical AnalysisIndependent statistical analysis of Speech Locator In-car Performance Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05054816).
- Speech Processing in Stuttering: Complete Statistical AnalysisIndependent statistical analysis of Speech Processing in Stuttering: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04929184).
- SPEEDIndependent statistical analysis of Patient Actor Training to Improve HIV Services for Adolescents in Kenya: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPEEDIndependent statistical analysis of Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery: Complete Statistical AnalysisIndependent statistical analysis of Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02978690).
- SPETIndependent statistical analysis of Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SPGblockIndependent statistical analysis of Sphenopalatine Ganglion Blocks RCT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03666663).
- Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines: Complete Statistical AnalysisIndependent statistical analysis of Sphenopalatine Ganglion Nerve Block vs. Elavil for Treatment of Transformed Migraines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPIN-CHATIndependent statistical analysis of Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Spinal Cord Stimulation to Restore Cough: Complete Statistical AnalysisIndependent statistical analysis of Spinal Cord Stimulation to Restore Cough: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00116337).
- Spinal Cord Stimulation to Treat Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Spinal Cord Stimulation to Treat Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02828436).
- Spinal Excitation to Enhance Mobility: Complete Statistical AnalysisIndependent statistical analysis of Spinal Excitation to Enhance Mobility: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03667573).
- Spinal Plasticity to Enhance Motor Retraining After Stroke: Complete Statistical AnalysisIndependent statistical analysis of Spinal Plasticity to Enhance Motor Retraining After Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03645122).
- SPINSIndependent statistical analysis of Stress CMR Perfusion Imaging in the United States (SPINS) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03192891).
- Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®): Complete Statistical AnalysisIndependent statistical analysis of Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SPIRE-1Independent statistical analysis of The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SPIRE-2Independent statistical analysis of The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SPIRE-HRIndependent statistical analysis of Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events: primary endpoint results, effect estimate with confidence interval, sample-size…
- SPIRITIndependent statistical analysis of A Representational Intervention to Promote Preparation for End-of-life Decision Making: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01259011).
- SPIRITIndependent statistical analysis of Antiarrhythmic Effects of Spironolactone in Patients With ICDs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04495712).
- SPIRITIndependent statistical analysis of Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00244842).
- SPIRITIndependent statistical analysis of Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SPIRIT SVIndependent statistical analysis of SPIRIT Small Vessel Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00783796).
- SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study): Complete Statistical AnalysisIndependent statistical analysis of SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study): primary…
- SPIRITT – Second-Line Panitumumab Irinotecan Treatment Trial: Complete Statistical AnalysisIndependent statistical analysis of SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00418938).
- Spironolactone in Adult Congenital Heart Disease: Complete Statistical AnalysisIndependent statistical analysis of Spironolactone in Adult Congenital Heart Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01069510).
- SPLASHIndependent statistical analysis of A Multi-Component Alcohol and Sex Risk Intervention for College Students: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05180539).
- SPLDIndependent statistical analysis of Development of a Resiliency Training Program for Parents of Children With Specific Learning Disabilities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy: Complete Statistical AnalysisIndependent statistical analysis of Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Split-DoseIndependent statistical analysis of Evaluation of Half-Dose Molecular Breast Imaging With Wide Beam Reconstruction Processing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SpO2 System Accuracy Testing With Different Sensors: Complete Statistical AnalysisIndependent statistical analysis of SpO2 System Accuracy Testing With Different Sensors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01613222).
- SpO2 Validation of Noninvasive Red Diamond Disposable Pulse Oximeter Sensor: Complete Statistical AnalysisIndependent statistical analysis of SpO2 Validation of Noninvasive Red Diamond Disposable Pulse Oximeter Sensor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03124602).
- SPOTIndependent statistical analysis of UH3 Pragmatic Suicide Prevention Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02326883).